Potter, W., Shah, B., Shackelford, M., Davis, J., Boatwright, C., & Certo, J. (2017). ACTR-11. OVERALL SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH OPTUNE® CORRELATES WITH COMPLIANCE: CONSISTENCY ACROSS STUDIES. Neuro Oncol.
Citação norma ChicagoPotter, Wyatt, Bimal Shah, Melissa Shackelford, Joe Davis, Charles Boatwright, and Jeanine Certo. "ACTR-11. OVERALL SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH OPTUNE® CORRELATES WITH COMPLIANCE: CONSISTENCY ACROSS STUDIES." Neuro Oncol 2017.
Citação norma MLAPotter, Wyatt, et al. "ACTR-11. OVERALL SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH OPTUNE® CORRELATES WITH COMPLIANCE: CONSISTENCY ACROSS STUDIES." Neuro Oncol 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.